Advertisement
Canada markets close in 6 hours 29 minutes
  • S&P/TSX

    22,006.96
    -4.76 (-0.02%)
     
  • S&P 500

    5,080.66
    +10.11 (+0.20%)
     
  • DOW

    38,459.84
    -43.85 (-0.11%)
     
  • CAD/USD

    0.7294
    -0.0026 (-0.35%)
     
  • CRUDE OIL

    82.84
    -0.52 (-0.62%)
     
  • Bitcoin CAD

    90,528.41
    -133.22 (-0.15%)
     
  • CMC Crypto 200

    1,429.08
    +4.98 (+0.35%)
     
  • GOLD FUTURES

    2,333.30
    -8.80 (-0.38%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.6420
    +0.0440 (+0.96%)
     
  • NASDAQ

    15,788.66
    +92.02 (+0.59%)
     
  • VOLATILITY

    15.89
    +0.20 (+1.28%)
     
  • FTSE

    8,072.31
    +27.50 (+0.34%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6815
    -0.0021 (-0.31%)
     

Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’

Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’

More than two years after hedge fund manager Kyle Bass started his quixotic crusade to challenge pharmaceutical patents he said lead to inflated drug prices, he doesn’t have much to show for it.